NAPNAP’s newest online CE course, Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention, features two of our members Deena Garner, DNP, APRN CPNP-PC and Alison Moriarty Daley, PhD, APRN, PPCNP-BC, FAAN, and will improve clinicians' knowledge and competence regarding human papillomavirus (HPV) vaccination recommendations and strategies for advocating for vaccination and improving vaccine uptake. This FREE CE activity offers 0.5 NAPNAP contact hours (0.5 Rx) and is available now!
This free activity is offered by Medscape and NAPNAP to inform pediatricians, primary care physicians, dermatologists, pediatric nurse practitioners, and physician assistants about the pathophysiology and characteristics of, and treatment options for, mild, moderate, and severe atopic dermatitis (AD) and how to facilitate shared decision making to improve patient adherence and outcomes. (Approved for 0.50 AMA PRA Category 1 credits(s)TM 0.50 ABIM MOC points, 0.50 NAPNAP Contact Hours(s) of which 0.25 contain pharmacology content). This activity is supported by an educational grant from Pfizer Inc. (Expires March 27, 2019)
This activity offered by cmecorner.com will address T2DM in pediatric patients which is rapidly progressing. The American Diabetes Association has developed criteria for screening diagnosis, and management considerations for T2DM in children and adolescents. (Approved for 0.75 NAPNAP contact hours, of which contain 0.25 pharmacology content) CME: 0.75 AMA PRA Category 1 CreditTM . (Expires April 30, 2019)
This activity offered by cmecorner.com discusses the most common inflammatory arthritis in the pediatric population. Over 300,000 children and adolescents are affected by JIA in the USA.The management of JIA represents a significant challenge to physicians, NPs, and other clinicians, particularly those in front-line specialties such as pediatrics and primary care. This activity will address timely diagnosis/classification of JIA and appropriate treatment, which are critical for preventing joint damage and improving long-term outcomes. Approved for 0.75 NAPNAP Contact Hour of which 0.25 contain pharmacology content. (Expires September 14, 2019).